BioVerdant, Inc., a private company
that utilizes biocatalysis to provide extremely cost effective Green
Chemistry solutions for chemical manufacture, today announced the
appointment of Dr. Berkeley W. Cue to its Scientific Advisory Board. Dr.
Cue is currently co- chairman of the Green Chemistry Institute's
Pharmaceutical Roundtable and was elected to the Governing Board of the
Green Chemistry Institute in 2003. Dr. Cue has spoken extensively on a
variety of aspects of Green Chemistry since 2000 and is widely considered
one of the industry's thought leaders.
Dr. Cue is a former Vice President of Pharmaceutical Sciences with
Pfizer Global Research and Development in Groton, Connecticut, where he
spent 29 years before retiring in April of 2004. While at Pfizer he created
and led Pfizer's Green Chemistry initiative. In 2004, he testified before
the House of Representatives Science Committee in support of the 2004
Federal Green Chemistry Act (HB 3970). Also in 2004, he was appointed to
the National Academies of Science Committee on Grand Challenges for
Sustainability in the Chemical Industry. In addition to his work with the
Green Chemistry Institute, Dr. Cue currently occupies seats on the
Scientific Advisory Boards of a variety of companies and academic
institutions. He also consults with several technology companies who serve
the pharmaceutical industry to create innovative solutions for
pharmaceutical science and manufacturing challenges.
Dr. Kim Albizati, Chief Executive Officer of BioVerdant stated, "We are
extremely happy that Buzz has chosen to work with us at BioVerdant. He has
proven to be very particular about who he works with in the fields of
biotransformations and green chemistry. The fact that Buzz enthusiastically
joined our SAB is a statement about our commitment and ability to become
leaders in the use of biotransformations in the Green Chemistry movement in
the pharmaceutical and related chemical-based industries."
About BioVerdant
BioVerdant is a private, venture-backed company headquartered in San
Diego, California with a corporate philosophy dedicated to green chemistry
and a focus on Biocatalysis and Chemical Process Research and Development
to provide cost effective and environmentally friendly solutions for drug
manufacturing. BioVerdant develops innovative chemoenzymatic solutions for
chemical manufacture that significantly reduce the time and cost of
manufacturing. The Company is transforming the synthesis of drug molecules
at industrial scales by integrating chemical, genomic and proteomic
sciences with the art of modern chemical process development and drug
manufacturing.
The scientists of BioVerdant are world leaders in enzyme discovery,
protein evolution, chemical process development and drug manufacturing and
the company was founded by expatriates of a major global pharmaceutical
company who are internationally recognized in these fields. The Company's
"Green Chemistry" approach to drug manufacturing is geared to minimizing
the effects and waste products of drug manufacturing on the environment.
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/01-29-2007/0004514848&EDATE=
